Skip to main content

Table 2 CMR parameters for T2DM patients with or without metabolic syndrome and the normal controls

From: Metabolic syndrome and myocardium steatosis in subclinical type 2 diabetes mellitus: a 1H-magnetic resonance spectroscopy study

  Normal (n = 30) Non-MetS (n = 23) MetS (n = 30)
1H-MRS
 Myocardium TG (%) 0.61 ± 0.22 1.16 ± 0.45* 1.54 ± 0.63*β
Cardiac function
 LVEDV (ml/m2) 75.89 ± 12.94 69.92 ± 14.33 66.20 ± 12.10*
 LVESV (ml/m2) 28.57 ± 6.17 25.17 ± 7.24 25.98 ± 6.54
 LVSV (ml/m2) 47.30 ± 8.12 44.74 ± 8.95 40.22 ± 8.945*
 LVEF (%) 62.47 ± 4.09 64.32 ± 6.06 60.82 ± 7.62
 LV mass (g/m2) 75.93 ± 14.33 82.91 ± 26.11 92.25 ± 22.81*
 LVGFI (%) 51.97 ± 6.60 47.33 ± 6.75 46.02 ± 9.43*
 LVMVR 0.55 ± 0.13 0.65 ± 0.15 0.76 ± 0.22*
LV stain
 Radial PS (%) 39.85 ± 7.64 39.98 ± 12.05 33.28 ± 9.00*β
 Circumferential PS (%) − 20.41 ± 2.50 − 19.34 ± 3.48 − 19.38 ± 2.32
 Longitudinal PS (%) − 15.71 ± 2.10 − 14.78 ± 3.48 − 12.67 ± 3.46*β
First perfusion
 Upslope 2.93 ± 0.78 2.45 ± 1.20 2.10 ± 1.19*
 TTM (s) 24.77 ± 11.01 30.44 ± 14.71 36.09 ± 14.57*
 MaxSI 24.19 ± 6.14 23.46 ± 9.13 20.65 ± 7.94
  1. The values are the mean ± SD. LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LVSV left ventricular stroke volume, LVEF left ventricular ejection fraction, LVGFI left ventricular global function index, LVMVR LV mass to LV end diastolic volume ratio, PS peak strain, TTM time to maximum signal intensity
  2. *P < 0.017 versus normal group
  3. βP < 0.017 versus T2DM in non-MetS group